<bill session="116" type="h" number="2339" updated="2022-11-01T20:02:15Z">
  <state datetime="2020-02-28T12:10:57-05:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2020-02-28T12:10:57-05:00"/>
  </status>
  <introduced datetime="2019-04-18"/>
  <titles>
    <title type="display">Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products, and for other purposes.</title>
    <title type="short" as="introduced">Reversing the Youth Tobacco Epidemic Act of 2019</title>
    <title type="short" as="reported to house">Reversing the Youth Tobacco Epidemic Act of 2019</title>
    <title type="short" as="reported to house" partial="1">Nicotine or Vaping Access Protection and Enforcement Act of 2019</title>
    <title type="short" as="reported to house" partial="1">NO VAPE Act of 2019</title>
    <title type="short" as="passed house">Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020</title>
    <title type="short" as="passed house">Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020</title>
  </titles>
  <sponsor bioguide_id="P000034"/>
  <cosponsors>
    <cosponsor bioguide_id="B001300" joined="2019-10-04"/>
    <cosponsor bioguide_id="B001281" joined="2019-12-23"/>
    <cosponsor bioguide_id="B001287" joined="2019-10-28"/>
    <cosponsor bioguide_id="B000574" joined="2019-11-05"/>
    <cosponsor bioguide_id="B001303" joined="2019-05-14"/>
    <cosponsor bioguide_id="B001278" joined="2020-01-07"/>
    <cosponsor bioguide_id="B001285" joined="2019-09-16"/>
    <cosponsor bioguide_id="C001072" joined="2020-02-06"/>
    <cosponsor bioguide_id="C001090" joined="2019-10-04"/>
    <cosponsor bioguide_id="C001055" joined="2019-10-11"/>
    <cosponsor bioguide_id="C001117" joined="2019-12-03"/>
    <cosponsor bioguide_id="C001091" joined="2019-12-11"/>
    <cosponsor bioguide_id="C001080" joined="2019-11-12"/>
    <cosponsor bioguide_id="C001084" joined="2020-02-21"/>
    <cosponsor bioguide_id="C001123" joined="2019-09-24"/>
    <cosponsor bioguide_id="C001049" joined="2020-02-21"/>
    <cosponsor bioguide_id="C001068" joined="2019-06-12"/>
    <cosponsor bioguide_id="C001124" joined="2019-09-09"/>
    <cosponsor bioguide_id="C001119" joined="2019-07-25"/>
    <cosponsor bioguide_id="C000984" joined="2019-07-09"/>
    <cosponsor bioguide_id="D000096" joined="2019-09-24"/>
    <cosponsor bioguide_id="D000598" joined="2019-09-24"/>
    <cosponsor bioguide_id="D000631" joined="2019-11-12"/>
    <cosponsor bioguide_id="D000627" joined="2019-10-21"/>
    <cosponsor bioguide_id="D000623" joined="2019-10-28"/>
    <cosponsor bioguide_id="D000610" joined="2019-09-16"/>
    <cosponsor bioguide_id="D000624" joined="2019-09-16"/>
    <cosponsor bioguide_id="E000179" joined="2019-06-20"/>
    <cosponsor bioguide_id="E000297" joined="2020-01-13"/>
    <cosponsor bioguide_id="E000296" joined="2019-12-06"/>
    <cosponsor bioguide_id="F000466" joined="2020-02-21"/>
    <cosponsor bioguide_id="F000454" joined="2019-09-16"/>
    <cosponsor bioguide_id="G000586" joined="2019-11-01"/>
    <cosponsor bioguide_id="G000587" joined="2020-02-04"/>
    <cosponsor bioguide_id="G000585" joined="2020-02-13"/>
    <cosponsor bioguide_id="G000583" joined="2019-09-24"/>
    <cosponsor bioguide_id="G000551" joined="2019-11-21"/>
    <cosponsor bioguide_id="H001080" joined="2020-02-18"/>
    <cosponsor bioguide_id="H000324" joined="2019-09-11"/>
    <cosponsor bioguide_id="H001081" joined="2019-10-11"/>
    <cosponsor bioguide_id="H001064" joined="2019-09-24"/>
    <cosponsor bioguide_id="H001087" joined="2019-09-06"/>
    <cosponsor bioguide_id="H001085" joined="2019-10-28"/>
    <cosponsor bioguide_id="H001068" joined="2019-10-21"/>
    <cosponsor bioguide_id="J000032" joined="2020-02-21"/>
    <cosponsor bioguide_id="J000294" joined="2020-01-24"/>
    <cosponsor bioguide_id="J000126" joined="2019-09-26"/>
    <cosponsor bioguide_id="K000385" joined="2019-10-08"/>
    <cosponsor bioguide_id="K000379" joined="2019-06-20"/>
    <cosponsor bioguide_id="K000389" joined="2019-10-28"/>
    <cosponsor bioguide_id="K000380" joined="2019-10-21"/>
    <cosponsor bioguide_id="K000381" joined="2019-09-11"/>
    <cosponsor bioguide_id="K000394" joined="2019-10-08"/>
    <cosponsor bioguide_id="K000210" joined="2019-07-25"/>
    <cosponsor bioguide_id="K000368" joined="2019-09-11"/>
    <cosponsor bioguide_id="K000391" joined="2019-09-24"/>
    <cosponsor bioguide_id="K000382" joined="2019-09-16"/>
    <cosponsor bioguide_id="L000559" joined="2019-10-11"/>
    <cosponsor bioguide_id="L000560" joined="2019-06-28"/>
    <cosponsor bioguide_id="L000557" joined="2020-02-21"/>
    <cosponsor bioguide_id="L000581" joined="2019-10-28"/>
    <cosponsor bioguide_id="L000586" joined="2019-09-26"/>
    <cosponsor bioguide_id="L000551" joined="2019-04-25"/>
    <cosponsor bioguide_id="L000592" joined="2020-02-21"/>
    <cosponsor bioguide_id="L000593" joined="2019-09-24"/>
    <cosponsor bioguide_id="L000287" joined="2019-08-09"/>
    <cosponsor bioguide_id="L000582" joined="2019-07-09"/>
    <cosponsor bioguide_id="L000397" joined="2019-11-13"/>
    <cosponsor bioguide_id="L000480" joined="2019-08-06"/>
    <cosponsor bioguide_id="L000570" joined="2019-10-30"/>
    <cosponsor bioguide_id="M001203" joined="2019-11-26"/>
    <cosponsor bioguide_id="M001185" joined="2020-01-24"/>
    <cosponsor bioguide_id="M001163" joined="2019-10-21"/>
    <cosponsor bioguide_id="M001208" joined="2020-01-28"/>
    <cosponsor bioguide_id="M001143" joined="2019-08-20"/>
    <cosponsor bioguide_id="M001166" joined="2019-10-30"/>
    <cosponsor bioguide_id="M001188" joined="2019-09-24"/>
    <cosponsor bioguide_id="M001160" joined="2019-11-13"/>
    <cosponsor bioguide_id="M001207" joined="2019-05-14"/>
    <cosponsor bioguide_id="N000002" joined="2020-01-30"/>
    <cosponsor bioguide_id="N000179" joined="2019-09-24"/>
    <cosponsor bioguide_id="N000191" joined="2019-05-30"/>
    <cosponsor bioguide_id="N000188" joined="2019-10-11"/>
    <cosponsor bioguide_id="N000147" joined="2019-07-09"/>
    <cosponsor bioguide_id="P000614" joined="2019-09-16"/>
    <cosponsor bioguide_id="P000604" joined="2019-10-11"/>
    <cosponsor bioguide_id="P000616" joined="2020-02-21"/>
    <cosponsor bioguide_id="P000597" joined="2019-06-28"/>
    <cosponsor bioguide_id="P000610" joined="2019-10-04"/>
    <cosponsor bioguide_id="P000607" joined="2019-09-24"/>
    <cosponsor bioguide_id="P000618" joined="2019-11-21"/>
    <cosponsor bioguide_id="P000617" joined="2019-09-26"/>
    <cosponsor bioguide_id="Q000023" joined="2019-06-12"/>
    <cosponsor bioguide_id="R000606" joined="2019-06-12"/>
    <cosponsor bioguide_id="R000602" joined="2020-01-30"/>
    <cosponsor bioguide_id="R000613" joined="2019-10-08"/>
    <cosponsor bioguide_id="R000616" joined="2019-09-24"/>
    <cosponsor bioguide_id="R000486" joined="2019-09-11"/>
    <cosponsor bioguide_id="R000599" joined="2019-10-21"/>
    <cosponsor bioguide_id="R000515" joined="2019-04-25"/>
    <cosponsor bioguide_id="R000577" joined="2019-06-12"/>
    <cosponsor bioguide_id="S001168" joined="2019-04-25"/>
    <cosponsor bioguide_id="S001205" joined="2019-11-13"/>
    <cosponsor bioguide_id="S001145" joined="2019-05-30"/>
    <cosponsor bioguide_id="S001216" joined="2019-09-11"/>
    <cosponsor bioguide_id="S000248" joined="2020-01-15"/>
    <cosponsor bioguide_id="S001185" joined="2019-06-20"/>
    <cosponsor bioguide_id="S001206" joined="2019-04-18"/>
    <cosponsor bioguide_id="S001208" joined="2020-01-21"/>
    <cosponsor bioguide_id="S001200" joined="2019-11-01"/>
    <cosponsor bioguide_id="S001175" joined="2019-12-23"/>
    <cosponsor bioguide_id="S001215" joined="2019-09-12"/>
    <cosponsor bioguide_id="S001201" joined="2019-06-12"/>
    <cosponsor bioguide_id="S001193" joined="2019-12-11"/>
    <cosponsor bioguide_id="S001156" joined="2019-12-05"/>
    <cosponsor bioguide_id="T000472" joined="2019-10-28"/>
    <cosponsor bioguide_id="T000193" joined="2019-09-16"/>
    <cosponsor bioguide_id="T000460" joined="2020-02-18"/>
    <cosponsor bioguide_id="T000481" joined="2019-09-09"/>
    <cosponsor bioguide_id="T000469" joined="2019-06-12"/>
    <cosponsor bioguide_id="T000483" joined="2019-11-21"/>
    <cosponsor bioguide_id="U000040" joined="2019-05-02"/>
    <cosponsor bioguide_id="V000130" joined="2020-02-21"/>
    <cosponsor bioguide_id="W000797" joined="2019-06-28"/>
    <cosponsor bioguide_id="W000187" joined="2020-02-11"/>
    <cosponsor bioguide_id="W000822" joined="2019-09-06"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-04-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-10-16">
      <text>Subcommittee Hearings Held.</text>
    </action>
    <action datetime="2019-11-13">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-11-13">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
    </action>
    <action datetime="2019-11-19">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-11-19" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 28 - 24.</text>
    </action>
    <action datetime="2020-02-21">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-402.</text>
    </action>
    <calendar datetime="2020-02-21" calendar="Union" number="324">
      <text>Placed on the Union Calendar, Calendar No. 324.</text>
    </calendar>
    <action datetime="2020-02-26T18:45:01-05:00">
      <text>Rules Committee Resolution H. Res. 866 Reported to House. Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.</text>
    </action>
    <action datetime="2020-02-27T14:45:12-05:00">
      <text>Rule H. Res. 866 passed House.</text>
    </action>
    <action datetime="2020-02-28T09:19:14-05:00">
      <text>Considered under the provisions of rule H. Res. 866.</text>
      <reference ref="CR H1257-1286" label="consideration"/>
    </action>
    <action datetime="2020-02-28T09:19:19-05:00">
      <text>Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.</text>
    </action>
    <action datetime="2020-02-28T09:21:27-05:00">
      <text>DEBATE - The House proceeded with 90 minutes of debate on H.R. 2339.</text>
    </action>
    <action datetime="2020-02-28T11:11:14-05:00">
      <text>The previous question was ordered pursuant to the rule.</text>
    </action>
    <action datetime="2020-02-28T11:11:43-05:00">
      <text>POSTPONED PROCEEDINGS - Pursuant to clause 1(c) of Rule XIX, further proceedings on H.R. 2339 were postponed.</text>
    </action>
    <action datetime="2020-02-28T11:42:12-05:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H1286-1289" label="consideration"/>
    </action>
    <action datetime="2020-02-28T11:43:31-05:00">
      <text>Mr. Walden moved to recommit with instructions to the Committee on Energy and Commerce.</text>
      <reference ref="CR H1286-1287" label="text"/>
    </action>
    <action datetime="2020-02-28T11:43:47-05:00">
      <text>Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to insert a new title at the end of the bill, "Born-Alive Abortion Survivors Protection."</text>
    </action>
    <action datetime="2020-02-28T11:56:12-05:00">
      <text>The previous question on the motion to recommit with instructions was ordered without objection.</text>
    </action>
    <action datetime="2020-02-28T12:03:25-05:00">
      <text>On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 220 (Roll no. 77).</text>
    </action>
    <vote how="roll" type="vote" roll="78" datetime="2020-02-28T12:10:57-05:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On passage Passed by the Yeas and Nays: 213 - 195 (Roll no. 78).</text>
      <reference ref="CR H1257-1262" label="text"/>
    </vote>
    <action datetime="2020-02-28T12:10:59-05:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2020-03-02">
      <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Hearings, Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="3174" relation="unknown"/>
    <bill session="116" type="hr" number="866" relation="procedurally-related"/>
    <bill session="116" type="h" number="4716" relation="unknown"/>
    <bill session="116" type="h" number="4742" relation="unknown"/>
    <bill session="116" type="s" number="3223" relation="unknown"/>
    <bill session="116" type="h" number="1570" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Cancer"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Child health"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health facilities and institutions"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Marketing and advertising"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
    <term name="Mental health"/>
    <term name="Minority health"/>
    <term name="Racial and ethnic relations"/>
    <term name="Research administration and funding"/>
    <term name="Retail and wholesale trades"/>
    <term name="Sales and excise taxes"/>
    <term name="State and local courts"/>
    <term name="State and local government operations"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments>
    <amendment number="h802"/>
  </amendments>
  <summary date="2020-03-09T15:40:29Z" status="Passed House">Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020

This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).

Among other requirements, the bill

 requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking; requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes; generally prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems; prohibits flavors other than tobacco in a tobacco product; prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances; increases the user fees that the FDA collects from manufacturers and importers; directs the FDA to regulate products containing nicotine not made or derived from tobacco plants (including nicotine from chemical synthesis, recombinant genetic technology, or extraction from non-tobacco plants); imposes an excise tax on nicotine that has been extracted, concentrated, or synthesized; provides funding through FY2025&#160;to support&#160;public education regarding tobacco regulation, public awareness regarding the harms associated with tobacco use, outreach to medically underserved communities regarding tobacco-use prevention and cessation, research grants related to tobacco-use prevention and cessation, and&#160;grants to health centers for tobacco-use cessation treatment; establishes and provides funding through FY2025&#160;for&#160;a demonstration grant program to develop strategies for smoking cessation (including of the use of menthol-flavored tobacco products) in medically underserved communities; beginning in 2024, waives coinsurance under Medicare for colorectal-cancer screening tests; specifies that a health insurance plan may still be treated, for&#160;certain tax-deduction purposes, as a high-deductible plan even if it does not have a deductible for certain inhalers or nebulizers;&#160; exempts certain cigars from premarket review requirements; increases civil penalties for certain violations of restrictions on the sale of tobacco products; and requires the Government Accountability Office to study e-cigarettes. &#160;&#160;</summary>
  <committee-reports>
    <report>H. Rept. 116-402</report>
  </committee-reports>
</bill>
